- Home
- AGMH vs SCNI Comparison
AGMH vs SCNI Comparison
Compare AGMH & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGMH
- SCNI
- Stock Information
- Founded
- AGMH 2015
- SCNI 2003
- Country
- AGMH Hong Kong
- SCNI Israel
- Employees
- AGMH N/A
- SCNI N/A
- Industry
- AGMH EDP Services
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGMH Technology
- SCNI Health Care
- Exchange
- AGMH Nasdaq
- SCNI Nasdaq
- Market Cap
- AGMH 3.5M
- SCNI 3.2M
- IPO Year
- AGMH 2018
- SCNI N/A
- Fundamental
- Price
- AGMH $2.19
- SCNI $2.47
- Analyst Decision
- AGMH
- SCNI
- Analyst Count
- AGMH 0
- SCNI 0
- Target Price
- AGMH N/A
- SCNI N/A
- AVG Volume (30 Days)
- AGMH 817.1K
- SCNI 1.1M
- Earning Date
- AGMH 07-11-2025
- SCNI 08-14-2025
- Dividend Yield
- AGMH N/A
- SCNI N/A
- EPS Growth
- AGMH N/A
- SCNI N/A
- EPS
- AGMH 6.43
- SCNI N/A
- Revenue
- AGMH $32,044,575.00
- SCNI $658,000.00
- Revenue This Year
- AGMH N/A
- SCNI N/A
- Revenue Next Year
- AGMH N/A
- SCNI N/A
- P/E Ratio
- AGMH $0.34
- SCNI N/A
- Revenue Growth
- AGMH N/A
- SCNI N/A
- 52 Week Low
- AGMH $1.09
- SCNI $1.90
- 52 Week High
- AGMH $109.50
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- AGMH 38.26
- SCNI 49.52
- Support Level
- AGMH $2.06
- SCNI $2.15
- Resistance Level
- AGMH $2.59
- SCNI $2.70
- Average True Range (ATR)
- AGMH 0.33
- SCNI 0.22
- MACD
- AGMH 0.01
- SCNI 0.01
- Stochastic Oscillator
- AGMH 35.06
- SCNI 32.99
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.